$CMPO
CompoSecure, Inc.

2021 Q3 Form 10-Q Financial Statement

#000110465921139224 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2021 Q1
Revenue $0.00 $0.00 $63.72M
YoY Change
Cost Of Revenue $30.04M $27.60M $29.41M
YoY Change
Gross Profit $36.15M $35.10M $34.32M
YoY Change
Gross Profit Margin 53.85%
Selling, General & Admin $14.55M $10.70M $8.057M
YoY Change
% of Gross Profit 40.26% 30.48% 23.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.640M $2.580M $2.585M
YoY Change
% of Gross Profit 7.3% 7.35% 7.53%
Operating Expenses $498.6K $1.394M $8.057M
YoY Change 69148.61%
Operating Profit -$498.6K -$1.394M $26.26M
YoY Change 69438.49%
Interest Expense $675.5K -$20.26M -$2.643M
YoY Change
% of Operating Profit -10.07%
Other Income/Expense, Net $675.5K -$20.26M -$3.037M
YoY Change
Pretax Income $176.9K -$21.66M $23.22M
YoY Change -24670.83%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $176.9K -$21.66M $23.22M
YoY Change -24773.78%
Net Earnings / Revenue 36.44%
Basic Earnings Per Share
Diluted Earnings Per Share $6.300K -$748.2K $299.5K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3 2021 Q2 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.16K $18.05K $414.3K
YoY Change
Cash & Equivalents $15.16K $18.05K $4.976M
Short-Term Investments
Other Short-Term Assets $225.4K $334.1K $416.7K
YoY Change
Inventory
Prepaid Expenses $225.4K $334.1K
Receivables
Other Receivables
Total Short-Term Assets $240.5K $352.1K $831.0K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $236.3M $236.3M $236.3M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $236.3M $236.3M $236.3M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $240.5K $352.1K $831.0K
Total Long-Term Assets $236.3M $236.3M $236.3M
Total Assets $236.5M $236.6M $237.1M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.470M $2.211M $1.336M
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.638M $2.251M $1.336M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $44.84M $45.52M $25.25M
YoY Change
Total Long-Term Liabilities $44.84M $45.52M $25.25M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.638M $2.251M $1.336M
Total Long-Term Liabilities $44.84M $45.52M $25.25M
Total Liabilities $47.48M $47.77M $26.59M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$47.14M -$47.32M -$25.67M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$47.14M -$47.32M -$172.2M
YoY Change
Total Liabilities & Shareholders Equity $236.5M $236.6M $237.1M
YoY Change

Cashflow Statement

Concept 2021 Q3 2021 Q2 2021 Q1
OPERATING ACTIVITIES
Net Income $176.9K -$21.66M $23.22M
YoY Change -24773.78%
Depreciation, Depletion And Amortization $2.640M $2.580M $2.585M
YoY Change
Cash From Operating Activities -$131.3K -$436.3K $6.105M
YoY Change 18211.02%
INVESTING ACTIVITIES
Capital Expenditures $2.650M $970.0K $275.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.650M -$970.0K -$275.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 128.4K 40.00K -$14.28M
YoY Change 17807.95%
NET CHANGE
Cash From Operating Activities -131.3K -436.3K $6.105M
Cash From Investing Activities -2.650M -970.0K -$275.0K
Cash From Financing Activities 128.4K 40.00K -$14.28M
Net Change In Cash -2.890K -396.3K -$8.446M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$131.3K -$436.3K $6.105M
Capital Expenditures $2.650M $970.0K $275.0K
Free Cash Flow -$2.781M -$1.406M $5.830M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Assets Current
AssetsCurrent
240546
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1038304
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001823144
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Out Of Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersOutOfLevel3
0
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-25664481
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39687
dei Entity Registrant Name
EntityRegistrantName
Roman DBDR Tech Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2749902
dei Entity Address Address Line1
EntityAddressAddressLine1
2877 Paradise Rd. #702
dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89109
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
618-2524
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15158
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
603615
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
225388
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
434689
CY2021Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236289574
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236215089
CY2021Q3 us-gaap Assets
Assets
236530120
CY2020Q4 us-gaap Assets
Assets
237253393
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
2470093
dbdr Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
74485
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9283876
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
98112
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
168400
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2638493
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98112
CY2021Q3 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
CY2020Q4 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
CY2021Q3 us-gaap Liabilities
Liabilities
47482131
CY2020Q4 us-gaap Liabilities
Liabilities
35657874
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47143789
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34596260
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-47143210
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-34595681
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236530121
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
237253393
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
498591
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3338138
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
717
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-498591
us-gaap Operating Income Loss
OperatingIncomeLoss
-3338138
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-717
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3040
us-gaap Investment Income Interest
InvestmentIncomeInterest
74485
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
672462
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-9283876
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
675502
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9209391
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
176911
us-gaap Net Income Loss
NetIncomeLoss
-12547529
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-717
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-34595681
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
8931200
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-25664481
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21655640
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-47320121
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
176911
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-47143210
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-717
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
24283
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2371981
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-756857
us-gaap Profit Loss
ProfitLoss
-12547529
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-717
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15158
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-209300
CY2020Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-717
CY2020Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
13217
CY2020Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12500
dbdr Proceeds From Other Related Party Debt
ProceedsFromOtherRelatedPartyDebt
170000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1600
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
168400
CY2020Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
717
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-588457
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
603615
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q3 dbdr Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
5000
CY2020Q3 dbdr Offering Costs Paid By Sponsor In Exchange For Issuance Of Founder Shares
OfferingCostsPaidBySponsorInExchangeForIssuanceOfFounderShares
25000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15158
CY2021Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
236289574
dbdr Working Capital Deficit
WorkingCapitalDeficit
2247947
CY2021Q3 dbdr Franchise And Income Taxes Payable
FranchiseAndIncomeTaxesPayable
150000
dbdr Interest Income Earned From Trust Account Available To Pay Tax Obligations
InterestIncomeEarnedFromTrustAccountAvailableToPayTaxObligations
98374
CY2021Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q3 dbdr Minimum Net Tangible Assets Upon Redemption Of Temporary Equity
MinimumNetTangibleAssetsUponRedemptionOfTemporaryEquity
5000001
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
224400000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29119658
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29119025
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
236191200
CY2020Q4 dbdr Retained Earnings Accumulated Deficit Total
RetainedEarningsAccumulatedDeficitTotal
-34596259
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-34595681
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
236191200
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25665059
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
236191200
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47320699
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-47320121
dbdr Units Issued During Period Shares New Issues
UnitsIssuedDuringPeriodSharesNewIssues
23156000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
-29279949
CY2021Q1 dbdr Stockholders Equity Total
StockholdersEquityTotal
-25664481
CY2021Q2 dbdr Stockholders Equity Total
StockholdersEquityTotal
-47320121
CY2020Q4 dbdr Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
236191200
dbdr Proceeds From Issuance Of Temporary Equity
ProceedsFromIssuanceOfTemporaryEquity
231560000
dbdr Temporary Equity Proceeds Allocated To Warrants
TemporaryEquityProceedsAllocatedToWarrants
-12156900
dbdr Temporary Equity Issuance Costs
TemporaryEquityIssuanceCosts
-12491903
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
29280003
CY2021Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
236191200
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q3 dbdr Total Offering Costs
TotalOfferingCosts
13206613
dbdr Sale Of Stock Underwriting Fees
SaleOfStockUnderwritingFees
4631200
CY2021Q3 dbdr Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
8104600
dbdr Sale Of Stock Other Offering Costs
SaleOfStockOtherOfferingCosts
470813
CY2021Q3 dbdr Offering Cost Charged To Expense
OfferingCostChargedToExpense
714710
CY2021Q3 dbdr Offering Cost Charged To Stock Holders Equity
OfferingCostChargedToStockHoldersEquity
12491903
CY2021Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
22415400
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation maximum of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10200
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
50200
CY2021Q3 dbdr Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
3
CY2021Q3 dbdr Deferred Fee Per Unit
DeferredFeePerUnit
0.35
dbdr Net Tangible Asset
NetTangibleAsset
5000001
dbdr Transaction Costs
TransactionCosts
50000000
dbdr Remaining Trust Cash
RemainingTrustCash
210000000
dbdr Net Indebtedness Of Composecure
NetIndebtednessOfComposecure
250000000
dbdr Amount Of Cash On Hand At Composecure
AmountOfCashOnHandAtComposecure
5000000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Into Level3
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
23644544
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3810618
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
27455162
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
19594960
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
36739038

Files In Submission

Name View Source Status
0001104659-21-139224-index-headers.html Edgar Link pending
0001104659-21-139224-index.html Edgar Link pending
0001104659-21-139224.txt Edgar Link pending
0001104659-21-139224-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210930.xsd Edgar Link pending
tmb-20210930x10q.htm Edgar Link pending
tmb-20210930x10q_htm.xml Edgar Link completed
tmb-20210930xex31d1.htm Edgar Link pending
tmb-20210930xex31d2.htm Edgar Link pending
tmb-20210930xex31d3.htm Edgar Link pending
tmb-20210930xex32d1.htm Edgar Link pending
tmb-20210930xex32d2.htm Edgar Link pending
tmb-20210930xex32d3.htm Edgar Link pending
tmb-20210930_cal.xml Edgar Link unprocessable
tmb-20210930_def.xml Edgar Link unprocessable
tmb-20210930_lab.xml Edgar Link unprocessable
tmb-20210930_pre.xml Edgar Link unprocessable